[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review

July 2021 | 39 pages | ID: ABCFA96D3FCEN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Active Biotech AB (Active Biotech) is a biotechnology company that focuses on the development of therapeutics in the field of cancer, eye disorders and inflammatory/neurodegenerative diseases. The company’s pipeline products in development include Anyara or Naptumomab Estafenatox (naptumomab) for the treatment of solid tumors; tasquinimod for multiple myeloma; and laquinimod for both wetAMD and Uveitis. It has partnership with NeoTX Therapeutics Ltd and with the Perelman School of Medicine, University of Pennsylvania. Active Biotech is headquartered in Lund, Sweden.

Active Biotech AB Key Recent Developments

Nov 05,2020: Active Biotech interim report January – September 2020
Aug 06,2020: Active Biotech interim report January - June 2020
Apr 23,2020: Active Biotech interim report January - March 2020
Feb 05,2020: Active Biotech announces new direction

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Active Biotech AB - Key Facts
Active Biotech AB - Key Employees
Active Biotech AB - Key Employee Biographies
Active Biotech AB - Major Products and Services
Active Biotech AB - History
Active Biotech AB - Company Statement
Active Biotech AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Active Biotech AB - Business Description
Active Biotech AB - SWOT Analysis
SWOT Analysis - Overview
Active Biotech AB - Strengths
Active Biotech AB - Weaknesses
Active Biotech AB - Opportunities
Active Biotech AB - Threats
Active Biotech AB - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Active Biotech AB, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 05, 2020: Active Biotech interim report January – September 2020
Aug 06, 2020: Active Biotech interim report January - June 2020
Apr 23, 2020: Active Biotech interim report January - March 2020
Feb 05, 2020: Active Biotech announces new direction

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Active Biotech AB, Key Facts
Active Biotech AB, Key Employees
Active Biotech AB, Key Employee Biographies
Active Biotech AB, Major Products and Services
Active Biotech AB, History
Active Biotech AB, Other Locations
Active Biotech AB, Subsidiaries
Active Biotech AB, Key Competitors
Active Biotech AB, Ratios based on current share price
Active Biotech AB, Annual Ratios
Active Biotech AB, Annual Ratios (Cont...1)
Active Biotech AB, Interim Ratios
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Active Biotech AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Active Biotech AB, Performance Chart (2016 - 2020)
Active Biotech AB, Ratio Charts
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Active Biotech AB, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications